Medicare beneficiaries in all states, the District of Columbia and Puerto Rico are expected to able to buy insurance that caps monthly insulin premiums at $35, for an average annual savings of $446 for the approximate 1.3 million beneficiaries who could benefit from the demo, CMS said Tuesday (May 26). The capped insulin costs are part of a Medicare demonstration, announced March 11 , that has been in the works since last year. The demo covers all insulin products, including...